StockData
RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Retension Pharmaceuticals, Inc.

$16.33+2.26 (+16.06%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Retension Pharmaceuticals, Inc. revenue by segment

No segment breakdown reported

Retension Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.